Navigation Links
Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2011 /PRNewswire/ -- Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United States. The launch will occur in the technical exhibit at the American Academy of Dermatology annual meeting in New Orleans. Indicated for the treatment of acne, Stiefel will market two products OTC under the PanOxyl® Brand.  PanOxyl® Acne Creamy Wash will be available in 4% BPO and 8% BPO.  

PanOxyl® 4% and 8% BPO Acne Creamy Washes feature a patented delivery system including Dimethyl Isosorbide (DMI) that solubilizes BPO and greatly reduces particulate-based skin irritation and inflammation commonly experienced with conventional BPO formulations.  Both products are thick, creamy formulations which provide excellent efficacy and rapid reduction in acne lesions.  

"Stiefel's Creamy Wash formulations have been physician favorites for several years," said Shayne Sundholm, vice president, U.S. Non Prescription Dermatology, Stiefel.  "And we are excited to be able to offer them to a larger number of consumers through the retail market."  

A comprehensive marketing campaign directed toward dermatologists and pharmacists will communicate details of the new PanOxyl® 4% and 8% BPO Acne Creamy Washes.  Product will be available for shipment in May 2011.  

PanOxyl® Acne Management product line offers different formulations for the treatment and prevention of acne on the face, chest and back.

About Stiefel, a GSK company  

Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin.  Stiefel's dedication to innovation, along with its focus on pharmaceutical, over-the-counter and aesthetic dermatology products, has established Stiefel as a world leader in the skin health industry.  To learn more about Stiefel, visit

SOURCE Stiefel, a GSK company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
2. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
3. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):